US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Canaquest Medical Corp
(OP:
CANQF
)
0.0001
UNCHANGED
Last Price
Updated: 9:32 AM EDT, Jun 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Canaquest Medical Corp
New Leaders Of NY Cannabis Reg Body And Recent Industry Appointments You Need To Know About
↗
June 12, 2024
Chris Alexander, the former head of the New York Office of Cannabis Management (OCM), resigned in May. Gov. Kathy Hochul first announced that Alexander's contract would not be renewed following its end...
Via
Benzinga
Topics
Cannabis
NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players
October 31, 2023
Via
ACCESSWIRE
CANAQUEST Announces Award of European Cannabinoid Patent
September 19, 2023
Via
ACCESSWIRE
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
July 26, 2023
Via
ACCESSWIRE
CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)
April 25, 2023
Via
ACCESSWIRE
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
December 08, 2022
Via
ACCESSWIRE
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD
December 12, 2022
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated...
Via
iCrowdNewswire
CBD Combined With Essential Fatty Acids Is 40% More Efficient In Epilepsy Seizure Reduction Than Regular CBD, New Study
↗
December 09, 2022
CANAQUEST MEDICAL CORP (OTCPK:CANQF), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous...
Via
Benzinga
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
September 08, 2022
Via
ACCESSWIRE
The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More
↗
April 30, 2021
Cannabis stocks traded mostly in the green this week, as we got into earnings season. “While there were a lot of companies reportin...
Via
Benzinga
Topics
Cannabis
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
April 29, 2021
TORONTO, ON / ACCESSWIRE / April 29, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing formulations...
From
CanaQuest Medical Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Cannabis Movers & Shakers: CanaQuest, Terra Tech, BioSteel, Halo Collective, Rolling Stone Culture Council, Australis
↗
April 13, 2021
CanaQuest Names Wall Street Expert Rob Rinderman Director Of Communications CanaQuest Medical Corp (OTC PINK: CANQF) a biotechnology company focusing on cannabis, has hired Rob...
Via
Benzinga
Topics
Cannabis
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
April 07, 2021
TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing health and wellness...
From
CanaQuest Medical Corp.
Via
AccessWire
Topics
Cannabis
Initial Public Offering
